Veru

Veru Moves Forward with Late-Stage COVID Study Despite FDA Roadblock
Veru Moves Forward with Late-Stage COVID Study Despite FDA Roadblock
BioSpace
Veru
COVID-19
sabizabulin
clinical trials
Flag link:
FDA rejects Covid-19 drug over uncertainties around small trial
FDA rejects Covid-19 drug over uncertainties around small trial
Endpoints
Veru
clinical trials
COVID-19
ARDS
sabizabulin
Flag link:
FDA Cites ‘Uncertainties’ in Veru's COVID-19 Antiviral Data Ahead of Adcomm
FDA Cites ‘Uncertainties’ in Veru's COVID-19 Antiviral Data Ahead of Adcomm
BioSpace
Veru
FDA
antivirals
COVID-19
Flag link:
Veru, Immunome Tout Positive Data for COVID-19 Therapeutics
Veru, Immunome Tout Positive Data for COVID-19 Therapeutics
BioSpace
Veru
Immunome
COVID-19
clinical trials
Flag link:
Experimental drug cut severe COVID-19 deaths in half, early data shows
Experimental drug cut severe COVID-19 deaths in half, early data shows
Beckers Hospital Review
Veru
COVID-19
clinical trials
sabizabulin
Flag link:
Edesa finds a signal in severely ill Covid-19 patients
Edesa finds a signal in severely ill Covid-19 patients
EP Vantage
Edesa Biotech
COVID-19
Sorrento Therapeutics
Synairgen
Implicit Bioscience
Atriva Therapeutics
Veru
Flag link:
Early Covid-19 “win” boosts Veru
Early Covid-19 “win” boosts Veru
EP Vantage
Veru
VERU-111
COVID-19
Flag link:
Veru touts novel breast cancer treatment strategy as drug nears phase 3
Veru touts novel breast cancer treatment strategy as drug nears phase 3
Fierce Biotech
Veru
clinical trials
enobosarm
breast cancer
Flag link: